Keros Therapeutics Files Definitive Proxy Statement
Ticker: KROS · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1664710
| Field | Detail |
|---|---|
| Company | Keros Therapeutics, Inc. (KROS) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, annual-meeting
Related Tickers: KROS
TL;DR
KROS DEF 14A filed - annual meeting proxy details out.
AI Summary
Keros Therapeutics, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 23, 2025, for the fiscal year ending December 31, 2025. The filing pertains to the company's annual meeting and related corporate governance matters. Keros Therapeutics is a pharmaceutical preparations company located in Lexington, MA.
Why It Matters
This filing provides shareholders with essential information regarding the company's upcoming annual meeting, including details on director elections and other corporate actions, enabling informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for publicly traded companies and does not inherently indicate new risks.
Key Players & Entities
- Keros Therapeutics, Inc. (company) — Registrant
- 0001104659-25-037982 (filing_id) — Accession Number
- 20250423 (date) — Filing Date
- 20250604 (date) — Period of Report
- 1050 WALTHAM STREET, SUITE 302 (address) — Business Address
- LEXINGTON, MA (location) — Business Address City/State
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, providing details on matters to be voted upon.
When was this DEF 14A filed by Keros Therapeutics, Inc.?
This DEF 14A was filed on April 23, 2025.
What is the fiscal year end for Keros Therapeutics, Inc. as stated in the filing?
The fiscal year end for Keros Therapeutics, Inc. is December 31.
What is the Standard Industrial Classification (SIC) code for Keros Therapeutics, Inc.?
The SIC code for Keros Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is Keros Therapeutics, Inc. located?
Keros Therapeutics, Inc. is located at 1050 Waltham Street, Suite 302, Lexington, MA.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Keros Therapeutics, Inc. (KROS).